Re: Treatment Outcomes and Resource Use of Patients With Neurogenic Detrusor Overactivity Receiving Botulinum Toxin A (BOTOX) Therapy in Germany.

Penson DF
J Urol. 2011 185 (4): 1383-4

PMID: 22098977 · DOI:10.1016/S0022-5347(11)60302-9

MeSH Terms (7)

Botulinum Toxins, Type A Cost of Illness Female Humans Male Urinary Bladder, Neurogenic Urinary Bladder, Overactive

Connections (1)

This publication is referenced by other Labnodes entities: